Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapyM A Levesque, D Katsaros, M Massobrio, et al.Anticancer Research|February 24, 2001
Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patientsR Bellino, P Cortese, S Danese, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2013
A simple and reproducible prognostic index in luminal ER-positive breast cancersI Castellano, L Chiusa, A M Vandone, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) GroupL Del Mastro, B Dozin, E Aitini, et al.Journal of Chemotherapy (Florence, Italy)|April 1, 2006
Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancerF Montemurro, M Gatti, S Redana, et al.Anticancer Research|July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survivalA Berruti, P Zola, T Buniva, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2002
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapseM Tampellini, A Berruti, G Gorzegno, et al.Tumori|October 4, 2000
Sentinel lymph node and breast cancer staging: final results of the Turin Multicenter StudyP S Casalegno, S Sandrucci, M Bellò, et al.Pageof 2